10 September 2021 | News
Additional eight new lines planned to launch in Q3 2022
Cytiva continues to expand its manufacturing capacity for bioprocessing single-use consumables in China. In collaboration with Wego Pharmaceutical Co. Ltd, one of the largest healthcare technology suppliers in the country, the two companies are expanding an existing facility jointly launched in 2018.
These newly added manufacturing lines will triple the supply capacity of single-use consumables in the Asia-Pacific region. The planned expansion will consist of an additional eight new manufacturing lines, two of which are expected to launch by the end of 2021; with the other six lines scheduled in Q3 2022.
It adds 1300 square meters to the manufacturing area of the ISO Class 7 cleanroom and also includes a 1200 square meters warehouse to further save lead time and increase flexibility for customers.
These expansions are part of the recently-announced $1.5 billion-dollar investment by Cytiva and Pall Corporation. In addition to the increased capacity, Cytiva also brings new products, 100L to 1,000L Xcellerex mixer bags, to the expanded facility’s manufacturing portfolio.
The new products will incorporate Fortem technology - Cytiva’s materially advanced, single-use characterized film, and its local manufacture enhances our ability to provide business continuity for our customers.